Singapore, June 4 -- A ground-breaking test to diagnose liver fibrosis has received a boost after lead researcher, Professor Chamindie Punyadeera, was selected on to the prestigious LuminaX HealthTech Accelerator Programme.

The LuminaX HealthTech Accelerator is delivered by Cohort Innovation Space, located in the Gold Coast Health and Knowledge Precinct (GCHKP), Australia's emerging hub for health, research and technology innovation.

Australia's Griffith University research uses salivary biomarkers to diagnose the condition which is characterised by excessive accumulation of scar tissue which replaces normal liver tissue and disrupts the organ's structure and function.

The condition can lead to more severe liver damage culminating in c...